The launch of BrightMeds GLP-1 marks a crucial shift in how healthcare providers approach hyperglycemia. This advanced medication type delivers a distinctive mechanism of action that also reduces sugar but can facilitate a reduction in weight and improve heart-related outcomes. Early results sugg